Table 4.
Quality control metrics summary of the RNA-seq data derived from blood samples of 10 PGP-UK participants.
| Sample ID | RIN | Uniquely Aligned, % |
Duplicated Reads, % | GC Content, % | ||
|---|---|---|---|---|---|---|
| Read 1 | Read 2 | Read 1 | Read 2 | |||
| uk35C650 | 8.8 | 88.8% | 83.2% | 80.6% | 53% | 56% |
| uk2E2AAE | 9.1 | 89.3% | 85.9% | 82.3% | 53% | 56% |
| uk2DF242 | 9.2 | 90.0% | 86.3% | 81.9% | 53% | 56% |
| uk740176 | 8.5 | 90.0% | 84.8% | 80.6% | 53% | 56% |
| uk33D02F | 8.3 | 87.0% | 85.5% | 82.6% | 53% | 56% |
| uk0C72FF | 7.9 | 86.7% | 85.0% | 82.5% | 53% | 56% |
| uk1097F9 | 8.7 | 86.1% | 86.5% | 82.6% | 54% | 57% |
| uk174659 | 9.3 | 90.4% | 84.4% | 81.3% | 53% | 56% |
| uk85AA3B | 8.6 | 89.0% | 84.9% | 81.2% | 53% | 56% |
| uk481F67 | 7.1 | 90.4% | 87.3% | 83.7% | 52% | 55% |
The table contains RIN value, percentages of uniquely aligned bases, as well as duplicated reads and GC contents percentages for both forward and reverse reads for each sample.